Browse

Lysophosphatidylcholine suppresses apoptotic cell death by inducing cyclooxygenase-2 expression via a Raf-1 dependent mechanism in human cholangiocytes

Cited 8 time in Web of Science Cited 8 time in Scopus
Authors
Gwak, G-Y; Yoon, J-H; Lee, S-H; Lee, S-M; Lee, H-S; Gores, G J
Issue Date
2006-07-01
Publisher
Springer Verlag
Citation
J Cancer Res Clin Oncol. 2006 Dec;132(12):771-9. Epub 2006 Jun 29.
Keywords
AnimalsApoptosis/*drug effectsBile Ducts/cytology/metabolismCell Line, TumorCyclooxygenase 2/*biosynthesis/*geneticsDose-Response Relationship, DrugEnzyme Induction/drug effectsGene Expression ProfilingHumansLysophosphatidylcholines/*pharmacologyMaleProto-Oncogene Proteins c-raf/*metabolismRNA, Messenger/drug effects/geneticsRatsRats, Sprague-DawleyReverse Transcriptase Polymerase Chain Reaction
Abstract
PURPOSE: The high incidence of biliary tract carcinoma in patients with anomalous pancreaticobiliary ductal junction (APBDJ) implicates that a compositional alteration in bile may contribute to the genesis of this cancer. Lysophosphatidylcholine (LPC) is generated in the bile of these patients. Given the role of cyclooxygenase-2 (COX-2) in biliary tract carcinogenesis, we postulated that LPC induces COX-2 in cholangiocytes. METHODS: The effect of LPC on COX-2 expression in cholangiocytes was evaluated by immunoblot analysis, real-time PCR and reporter gene assay. Apoptosis was induced by TRAIL treatment, and quantified using DAPI staining. RESULTS: Lysophosphatidylcholine increased COX-2 protein expression in cholangiocytes in a concentration- and time-dependent manner. LPC-induced Raf-1 activation was responsible for this COX-2 induction. Accordingly, LPC increased COX-2 mRNA levels in a Raf-1 dependent manner by stabilizing COX-2 mRNA. Finally, LPC attenuated TRAIL-mediated apoptosis through a COX-2/PgE2 dependent mechanism. CONCLUSIONS: Collectively, these results implicate that LPC inhibits cholangiocyte apoptosis by inducing COX-2 expression via a Raf-1 dependent mechanism. This anti-apoptotic signaling may participate in biliary tract carcinogenesis in APBDJ patients, and therefore, its interruption may be a viable chemopreventative strategy.
ISSN
0171-5216 (Print)
Language
English
URI
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16810500

https://hdl.handle.net/10371/27556
DOI
https://doi.org/10.1007/s00432-006-0125-5
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse